Clinical trial
An Observational Study of Statin Treatment Induced HDL Changes - Effect on Cardiovascular Disease
NCT01551784 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Statin Treatment Induced HDL Changes - Effect on Cardiovascular Disease
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- October 31, 2012
- Enrollment
- 120,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease